Glazer Capital LLC’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Glazer Capital LLC’s Portfolio REVBU Stock Details REVBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,035,652	Closed	-$11M	–	1038
2021 Q2	$11M	Hold	1,035,652	–	–	0.17%	171
2021 Q1	$10.8M	Hold	1,035,652	–	–	0.15%	195
2020 Q4	$11.2M	Buy	+1,035,652	New	+$10.5M	0.4%	81

Other funds holding REVBU

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glazer Capital LLC's REVBU Position: Q3 2021 in Review

Glazer Capital LLC sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q3 2021, closing a stake of 1,035,652 shares — an estimated $11M sold.

Glazer Capital LLC first reported a position in REVBU in Q4 2020 and held it in 3 quarters. The position peaked at $11.2M in Q4 2020. 3 funds tracked by Wall St. Rank hold REVBU as of Q3 2021.

Glazer Capital LLC reported no remaining Revelation Biosciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
Glazer Capital LLC sold 1,035,652 Revelation Biosciences, Inc. Unit shares in Q3 2021, an estimated $11M.
Glazer Capital LLC first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 3 quarters.
Glazer Capital LLC's Revelation Biosciences, Inc. Unit position peaked at $11.2M in Q4 2020.
3 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q3 2021.

Based on Glazer Capital LLC's 13F filing for Q3 2021, filed 15 Nov 2021.